Deep vein thrombosis and pulmonary embolism treatment progress

Eliquis (apixaban) has received marketing authorisation for the treatment of deep vein thrombosis and pulmonary embolism and the prevention of recurrent DVT and PE, in adults.

Source: Pharmacy Europe - July 3, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Industry News Haematology apixaban bristol-myers squibb deep vein thrombosis Eliquis Latest News pfizer pulmonary embolism Source Type: news